NCT07245420 Evaluation Of Cardiovascular Health Outcomes Among Survivors 2
| NCT ID | NCT07245420 |
| Status | Recruiting |
| Phase | — |
| Sponsor | St. Jude Children's Research Hospital |
| Condition | Health Behavior |
| Study Type | INTERVENTIONAL |
| Enrollment | 350 participants |
| Start Date | 2026-06 |
| Primary Completion | 2029-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 350 participants in total. It began in 2026-06 with a primary completion date of 2029-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Childhood cancer survivors who received certain treatments are at a higher risk of developing heart problems in the future. This study is looking at ways to educate childhood cancer survivors about that risk and encourage them to receive a recommended heart screening test.
Eligibility Criteria
Inclusion Criteria: * Childhood Cancer Survivor Study (CCSS) Participants * Age ≥26 years * Treated with cumulative doxorubicin equivalent anthracycline doses ≥100 mg/m2 with any/no radiation, or ≥15 Gy chest radiation with any/no anthracyclines * No history of cardiomyopathy * Has not had an echocardiogram in the previous 5 years * Has a history of successful completion of CCSS surveys * English-Speaking * Has not been enrolled in ECHOS-1 (pilot) Exclusion Criteria: • Currently participating in a long-term follow-up program that provides risk-based screening
Contact & Investigator
Matthew Ehrhardt, MD, MS, MPI
PRINCIPAL INVESTIGATOR
St. Jude Children's Research Hospital
Frequently Asked Questions
Who can join the NCT07245420 clinical trial?
This trial is open to participants of all sexes, aged 26 Years or older, studying Health Behavior. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07245420 currently recruiting?
Yes, NCT07245420 is actively recruiting participants. Contact the research team at referralinfo@stjude.org for enrollment information.
Where is the NCT07245420 trial being conducted?
This trial is being conducted at Memphis, United States.
Who is sponsoring the NCT07245420 clinical trial?
NCT07245420 is sponsored by St. Jude Children's Research Hospital. The principal investigator is Matthew Ehrhardt, MD, MS, MPI at St. Jude Children's Research Hospital. The trial plans to enroll 350 participants.